185 related articles for article (PubMed ID: 25968834)
1. Association of hormone therapy and incident gout: population-based case-control study.
Bruderer SG; Bodmer M; Jick SS; Meier CR
Menopause; 2015 Dec; 22(12):1335-42. PubMed ID: 25968834
[TBL] [Abstract][Full Text] [Related]
2. Use of diuretics and risk of incident gout: a population-based case-control study.
Bruderer S; Bodmer M; Jick SS; Meier CR
Arthritis Rheumatol; 2014 Jan; 66(1):185-96. PubMed ID: 24449584
[TBL] [Abstract][Full Text] [Related]
3. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
4. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women.
Sidney S; Petitti DB; Quesenberry CP
Ann Intern Med; 1997 Oct; 127(7):501-8. PubMed ID: 9313017
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen.
Canonico M; Carcaillon L; Plu-Bureau G; Oger E; Singh-Manoux A; Tubert-Bitter P; Elbaz A; Scarabin PY
Stroke; 2016 Jul; 47(7):1734-41. PubMed ID: 27256671
[TBL] [Abstract][Full Text] [Related]
6. Risk of endometrial cancer following estrogen replacement with and without progestins.
Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
[TBL] [Abstract][Full Text] [Related]
7. Preferential prescribing of tibolone and combined estrogen plus progestogen therapy in postmenopausal women.
Velthuis-Te Wierik EJ; Hendricks PT; Martinez C
Menopause; 2007; 14(3 Pt 1):518-27. PubMed ID: 17224856
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
[TBL] [Abstract][Full Text] [Related]
10. Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.
Renoux C; Dell'Aniello S; Brenner B; Suissa S
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):554-560. PubMed ID: 28326633
[TBL] [Abstract][Full Text] [Related]
11. Effect of hormone therapy on blood pressure and hypertension in postmenopausal women: a systematic review and meta-analysis.
Ferreira Campos L; de Andrade Costa G; Domingues Feitosa M; Ferreira Félix I; Gabrielli L; C Almeida MDC; Ml Aquino E; Aras Júnior R
Menopause; 2024 Jun; 31(6):556-562. PubMed ID: 38688468
[TBL] [Abstract][Full Text] [Related]
12. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
[TBL] [Abstract][Full Text] [Related]
13. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
Renoux C; Dell'aniello S; Garbe E; Suissa S
BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
[TBL] [Abstract][Full Text] [Related]
14. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy use and the risk of stroke.
Renoux C; Dell'aniello S; Garbe E; Suissa S
Maturitas; 2008 Dec; 61(4):305-9. PubMed ID: 18996656
[TBL] [Abstract][Full Text] [Related]
16. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy.
Petitti DB; Sidney S; Quesenberry CP; Bernstein A
Stroke; 1998 Jan; 29(1):23-8. PubMed ID: 9445323
[TBL] [Abstract][Full Text] [Related]
17. Serum uric acid levels and hormone therapy type: a retrospective cohort study of postmenopausal women.
Jung JH; Song GG; Lee YH; Kim JH; Hyun MH; Choi SJ
Menopause; 2018 Jan; 25(1):77-81. PubMed ID: 28796699
[TBL] [Abstract][Full Text] [Related]
18. Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.
Koskela-Niska V; Pukkala E; Lyytinen H; Ylikorkala O; Dyba T
Int J Cancer; 2013 Oct; 133(7):1680-8. PubMed ID: 23526244
[TBL] [Abstract][Full Text] [Related]
19. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
[TBL] [Abstract][Full Text] [Related]
20. Does menopausal hormone therapy reduce myocardial infarction risk if initiated early after menopause? A population-based case-control study.
Carrasquilla GD; Berglund A; Gigante B; Landgren BM; de Faire U; Hallqvist J; Leander K
Menopause; 2015 Jun; 22(6):598-606. PubMed ID: 25490112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
